President’s message: The global burden of cardiovascular disease

Anderson GF, Chu E. Expanding priorities—confronting chronic diseases in countries with low income. N Engl J Med 2007;356: 209–11.PubMedCrossRefGoogle Scholar

Sim K-H, Fong AYY. Cardiac services in Sarawak. Malaysia. Am Heart Hosp J 2007;5:100–2.Google Scholar

Gaziano TA. Reducing the burden of cardiovascular disease in the developing world. Health Aff (Millwood) 2007;1:13–24.CrossRefGoogle Scholar

Malaysia GDP—real growth rate. Available from: URL: www. indexmundi.com/malaysia/gdp_real_growth_rate.html. Accessed May 20, 2007.Google Scholar

Ge L, Ge J. The reasons coronary heart disease mortality has increased in China. J Am Heart Hosp 2007;5:97–9.Google Scholar

He ZX, Shi RF, Wu YJ, Tian YQ, Liu XJ, Wang SW, et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation 2003;108:1208–13.PubMedCrossRefGoogle Scholar

Ong TK, Chin SP, Liew CK, Chan WL, Seyfarth MT, Liew HB, et al. Accuracy of 64-row multidetector computed tomography in detecting coronary artery disease in 134 symptomatic patients: influence of calcification. Am Heart J 2006;151: 1323.e1–6.CrossRefGoogle Scholar

Thomas G. President’s message: advances in cardiovascular medicine. J Nucl Cardiol 2007;14:136–8.CrossRefGoogle Scholar

Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K. et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics. Circulation 2007;115:e69–171.PubMedCrossRefGoogle Scholar

Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419–24.PubMedCrossRefGoogle Scholar

Thomas GS. Should we screen asymptomatic individuals for coronary artery disease or implement universal lipid-lowering therapy? Cardiol Rev 2005;13:40–5.PubMedGoogle Scholar